The drugmaker said it agreed to pay RAPT Therapeutics shareholders $58 per share, with $1.9 billion upfront investment in cash.
Source link
GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments
Date:
More like thisRelated
Poisoning suspected in deaths of 10 lions in Tanzania conservation area
DAR ES SALAAM, Tanzania -- Authorities in northern Tanzania...
Main Kremlin party keeps control of Russia’s parliament after a carefully orchestrated vote
Main Kremlin party keeps control of Russia’s parliament after...
Oil Prices Fall for Fourth Day as Supply Concerns Ease
Improving flows through the Strait of Hormuz and prospects...